Due to the genetic similarity of both herpes simplex virus types (HSV-1 and HSV-2) , the development of a prophylactic-therapeutic vaccine which is proven effective against one type of the virus would provide fundamentals for vaccine-development for the other virus type. As of 2014, several vaccine candidates are in different stages of development as they are being tested for safety and efficacy, including at least four vaccine candidates in the US and one in Australia. As of 2014, several vaccine candidates are in different stages of development as they are being tested for safety and efficacy, including at least four vaccine candidates in the US and one in Australia. Herpes simplex virus type 1, or herpes-1, which causes around 80 of cases of oral herpes infections. The second type, herpes simplex type 2 (or HSV-2) , occurs most often on or near the sex organs and is sometimes called genital herpes. It is caused by a virus – either the herpes simplex virus type 1 (HSV-1) or the herpes simplex virus type 2 (HSV-2). So new approaches for suppressing and treating herpes infections are badly needed, and our findings indicate that inhibiting Akt should be a useful therapeutic strategy to pursue.
HSV type 1 is the herpes virus that is usually responsible for cold sores of the mouth, the so-called fever blisters. Planned Parenthood answers your questions about what testing and treatment options are available for this STD. Prescription antiviral medicines approved for the treatment of both types of herpes simplex include: Acyclovir. Many people choose to treat herpes simplex because treatment can relieve symptoms and shorten an outbreak. Now, scientists know that either type can be found in either the oral or genital area, as well as at other sites. Type 1 herpes virus can also cause genital herpes, but it mainly causes infection around the mouth. Herpes simplex virus 1 (HSV-1) , or oral herpes, is a virus that affects more than 70 percent of the world’s adult population.
Now, scientists know that either type can be found in either the oral or genital area, as well as at other sites. The team tested their treatment on mice infected with herpes simplex type 1, which causes lesions on the mouth and eye. HSV type 1 typically is responsible for cold sores while HSV type 2 causes genital outbreaks.